AtheroNova Inc. (OTCPK:AHRO) and AtheroNova Operations, Inc. filed voluntary petitions under Chapter 11 of the U.S. Bankruptcy Code in the U.S. Bankruptcy Court on March 2, 2015. AtheroNova will evaluate all options, including a Bankruptcy Court supervised asset sale process, for all or substantially all of its assets to a party who could potentially be interested in continuing its clinical programs.